Gut hormones: the future of obesity treatment?

被引:21
|
作者
McGavigan, Anne K. [1 ]
Murphy, Kevin G. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Invest Med, Sect Invest Med, London W12 0NN, England
基金
英国生物技术与生命科学研究理事会;
关键词
glucagon-like peptide-1; gut hormones; obesity; oxyntomodulin; pancreatic polypeptide; peptide YY; GLUCAGON-LIKE PEPTIDE-1; INHIBITS FOOD-INTAKE; REDUCES BODY-WEIGHT; PROOF-OF-CONCEPT; PANCREATIC-POLYPEPTIDE; RECEPTOR AGONISTS; INTRAVENOUS-INFUSION; ENERGY-INTAKE; IN-VITRO; OXYNTOMODULIN;
D O I
10.1111/j.1365-2125.2012.04278.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Obesity is a major worldwide health problem. The treatment options are severely limited. The development of novel anti-obesity drugs is fraught with efficacy and safety issues. Consequently, several investigational anti-obesity drugs have failed to gain marketing approval in recent years. Anorectic gut hormones offer a potentially safe and viable option for the treatment of obesity. The prospective utility of gut hormones has improved drastically in recent years with the development of longer acting analogues. Additionally, specific combinations of gut hormones have been demonstrated to have additive anorectic effects. This article reviews the current stage of anti-obesity drugs in development, focusing on gut hormone-based therapies.
引用
收藏
页码:911 / 919
页数:9
相关论文
共 50 条
  • [21] Bowels control brain: gut hormones and obesity
    Benjamin C. T. Field
    Owais B. Chaudhri
    Stephen R. Bloom
    Nature Reviews Endocrinology, 2010, 6 : 444 - 453
  • [22] Gut Hormones as Peripheral Anti Obesity Targets
    Small, Caroline J.
    Bloom, Stephen R.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2004, 3 (05) : 379 - 388
  • [23] Bowels control brain - gut hormones and obesity
    Bloom, Stephen R.
    ENDOCRINE JOURNAL, 2010, 57 : S192 - S192
  • [24] Thyroid hormones and treatment of obesity
    Krotkiewski, M
    INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (Suppl 2) : S116 - S119
  • [25] Thyroid hormones and treatment of obesity
    M Krotkiewski
    International Journal of Obesity, 2000, 24 : S116 - S119
  • [26] THE ROLE OF HORMONES IN THE TREATMENT OF OBESITY
    KUNDE, MM
    ANNALS OF INTERNAL MEDICINE, 1948, 28 (05) : 971 - 988
  • [27] GUT HORMONES AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH OBESITY AND DIABETES
    Iantorno, M.
    Campia, U.
    Di Daniele, N.
    Nistico, S.
    Forleo, G. B.
    Cardillo, C.
    Tesauro, M.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2014, 27 (03) : 433 - 436
  • [28] Newer pharmacological interventions directed at gut hormones for obesity
    Camilleri, Michael
    Acosta, Andres
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (08) : 1153 - 1164
  • [29] Obesity and the role of gut and adipose hormones in female reproduction
    Gosman, Gabriella G.
    Katcher, Heather I.
    Legro, Richard S.
    HUMAN REPRODUCTION UPDATE, 2006, 12 (05) : 585 - 601
  • [30] Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity
    Rovella, Valentina
    Rodia, Giuseppe
    Di Daniele, Francesca
    Cardillo, Carmine
    Campia, Umberto
    Noce, Annalisa
    Candi, Eleonora
    Della-Morte, David
    Tesauro, Manfredi
    NUTRIENTS, 2021, 13 (02) : 1 - 34